CDSCO monthly lab alert
CDSCO NSQ alert, October 2025: 211 drug batches flagged
By Blacklisted editorial team· Published 20 Nov 2025· Updated 20 Sep 2026· Source: CDSCO NSQ portal
In its October 2025 alert, the Central Drugs Standard Control Organisation listed 211 drug batches that failed quality tests, 63 at central laboratories and 148 at state drug-testing laboratories, from 161 manufacturers across 146 products. The most common failure was assay, and the most-represented manufacturing state was Himachal Pradesh. Products flagged include Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3), Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500), Calcium & Vitamin D3 Tablets (TISE-CAL).
211
Batches flagged
63 / 148
Central / state labs
Assay
Top reason
161
Manufacturers
Batches per month, last 12 alerts
Nov 2024Oct 2025 · 211
Full list of NSQ batches, October 2025
Download CSV| Product | Batch | Manufacturer | Reason declared NSQ | Tested by |
|---|---|---|---|---|
| Voligesic Gel (Diclofenac Diethylamine. Linseed Oil, Methyl Salicylate & Menthol Gel) | DE4G12Mfg 2024-07 · Exp 2027-06 | Scott- Edil Pharmacia LtdHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Vecuronium Bromide Injection IP 10 mg | L25DU002Mfg 2025-02 · Exp 2027-01 | Nixi Laboratories Pvt.Ltd VPO. Mouza OgliHimachal Pradesh | The sample does not conform to I.P. with respect to the Test for Water Content and Assay of Vecuronium BromideAssay | CDL, KolkataCDSCO lab |
| VITACRINE LC (Alpha Lipoic Acid, Folic Acid, Methylcobalamin, Pyridoxine Hydrochloride & Vitamin D3 Tablets) | BD250297BMfg 2025-02 · Exp 2027-01 | Bioaltus Pharmaceuticals Pvt. LtdHimachal Pradesh | Test for Disintegration onlyDisintegration | DTL, Bengaluru, KarnatakaState lab |
| VALET-PM (Paracetamol and Diclofenac Potassium Tablets) | MAW40523Mfg 2023-05 · Exp 2026-04 | Suraksha Pharma Pvt. LtdUttarakhand | Test for Disintegration onlyDisintegration | DTL, Bengaluru, KarnatakaState lab |
| V-Floxacin -BH (Enrofloxacin & Bromhexine HCL Oral Liquid) | VBL-053Mfg 2025-03 · Exp 2026-08 | Varsha Labs LLPKarnataka | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Trypsin-Chymotrypsin Tablets (CHYMORAL FORTE DS) | WBB1E020Mfg 2024-12 · Exp 2026-11 | Windlas Biotech Ltd. (Plant-2) Khasra No. 141 To 143 & 145Uttarakhand | The sample is not of standard quality for the reason stated under 'Description'.Description | CDL, KolkataCDSCO lab |
| Tramadol Hydrochloride and Acetaminophen Tablets (Paradol-T) | JTN25-096Mfg 2025-06 · Exp 2027-05 | Janya Biocare Pvt.LtdUttarakhand | Test For DissolutionDissolution | NCT of DelhiState lab |
| Telmisartan and Amlodipine Tablets (Teluse AM ) | T24119Mfg 2024-11 · Exp 2026-10 | Tiba Pharmaceuticals Pvt.Ltd | Assay of Amlodipine besylate 1.72 mg (34.40%) found as claimed 5 mg)Assay | DTL Baddi H.PState lab |
| Tadalafil Tablets I.P. 20 mg (TADAFIRE- 20) | 1528Mfg 2025-05 · Exp 2028-04 | Alpha Pharmaceuticals 41Haryana | The sample does not conform to I.P. with respect to the DissolutionDissolution | CDL, KolkataCDSCO lab |
| Stenflam SP | MMT-9435Mfg 2024-02 · Exp 2026-01 | Mayoford Pharma Near Railway CrossingHimachal Pradesh | The sample fails in the Assay contents of Paracetamol.Assay | MDTL Kathua,Jammu and KashmirState lab |
| Shicold-Plus | RL23222Mfg 2023-12 · Exp 2025-11 | Rachil Pharma 18-19 PHASE-1 Ind.Area Sansarpur Terrace HP | NSQOther | DTL Baddi H.PState lab |
| Sertralinc Tablets IP 50mg(Teslin-50) | 111T241Mfg 2024-10 · Exp 2027-09 | Vega Biotec Pvt. Ltd. 23Gujarat | DissolutionDissolution | DTL, Thrissur, KeralaState lab |
| Serratiopeptidase Tablets IP | MT240928Mfg 2024-10 · Exp 2026-09 | Plot No.11Uttarakhand | Sample fails the test DisintegrationDisintegration | DTL, Thiruvananthapuram, KeralaState lab |
| Seram DP | SRDPT602Mfg 2024-11 · Exp 2026-10 | Tulbros Formulations | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| SILNAC-P (Aceclofenac & Paracetamol Tablets IP) | TSC-250577Mfg 2025-02 · Exp 2027-01 | Prochem Pharmaceuticals Pvt. LtdUttarakhand | Test for Dissolution? onlyDissolution | DTL, Bengaluru, KarnatakaState lab |
| Rosuvastatin 10 mg, Aspirin 150 mg and Clopidogrel 75 mg Capsules | SIBP24283Mfg 2024-06 · Exp 2026-05 | Bioaltus Pharmaceuticals Pvt. LtdSikkim | Assay for RosuvastatinAssay | DTL, Bengaluru, KarnatakaState lab |
| Ramipril Tablets IP (Rexre-2.5) | MB-13247Mfg 2025-01 · Exp 2027-12 | Medistream Bioscience | Sample does not conform IP standard as it fails the test Dissolution and Assay of RamipirilAssay | DTL, Thrissur, KeralaState lab |
| Rabeprazole Sodium (EC) and Domperidone (SR) Capsules (TOTORAB-DSR PLUS) | 240612Mfg 2024-06 · Exp 2026-05 | Saiyam Healthcare | ContentOther | SDTL, PunjabState lab |
| Rabeprazole Sodium & Domperidone Tablets (Asterab-D) | BCT-24-1906Mfg 2025-03 · Exp 2027-02 | Biocenna Healthcare Pvt.Ltd.Kh.No.218Uttarakhand | Assay for Rabeprazole SodiumAssay | SDTL,Andhra Pradesh, VijayawadaState lab |
| Rabeprazole Gastro-resistant Tablets IP (RABIMIST-20) | TG24-1514EMfg 2024-07 · Exp 2026-06 | Athens Life SciencesHimachal Pradesh | Test for Dissolution and AssayAssay | DTL, Bengaluru, KarnatakaState lab |
| Rabeprazole Gastro- resistant Tablets IP 20 Mg | RABP45003Mfg 2024-10 · Exp 2026-09 | Sunrise International Labs Ltd. Plot No. 100Telangana | The sample does not comply DissolutionDissolution | DCL TelanganaState lab |
| Primaquine Tablets IP 7.5mg | MT445Mfg 2024-10 · Exp 2027-09 | Maxwell Life Science Pvt. Ltd. T-53 & T-81Maharashtra | The sample does not conform to the IP with respect to Assay of PrimaquineAssay | DTL, JaipurState lab |
| Pregabalin & Methlcobalamin Capsules IP (Neujan Capsules) | MMC-1957Mfg 2024-01 · Exp 2025-12 | Mayoford PharmaHimachal Pradesh | Test for Uniformity of WeightUniformity of weight/content | DTL, Bengaluru, KarnatakaState lab |
| Povidone Iodine Solution IP | 2503003Mfg 2025-03 · Exp 2027-02 | Biodeal Pharmaceutical Ltd. Vill. Saini MajraHimachal Pradesh | Sample fails the test AssayAssay | RDTL, Ernakulam, KeralaState lab |
| Povidone Iodine & Metronidazole Solution (IU Liquid) | GLO-002Mfg 2025-04 · Exp 2027-03 | Gentech Healthcare Pvt Ltd | The sample does not conform to the IP with respect to Assay.Assay | DTL, JaipurState lab |
| Povidone - Iodine Gargle Sepsadone 2% | DLE-4008Mfg 2025-02 · Exp 2027-01 | Daffohils Laboratories Pvt LtdUttarakhand | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Polygeline Intravenous Infusion (3.5% w/v Polygeline colloidal solution with electrolytes) (PENTACIL) | 24EPT020Mfg 2024-11 · Exp 2026-10 | Pentagon Labs Ltd. 16C/16D | The sample does not conform to claim as per Patent and Proprietary in respect to the Test of Particulate matter and Assay of Potassium, ChlorideAssay | RDTL, ChandigarhCDSCO lab |
| Paracetamol, Phenyephrine and Chlorpheniramine Suspension IP (Maticold Suspension) | ALE012CMfg 2025-05 · Exp 2026-04 | Haustus Biotech Pvt Ltd | AssayAssay | DTL Baddi H.PState lab |
| Paracetamol Tablets IP 650mg, | PCT25092Mfg 2025-05 · Exp 2027-04 | Vivek Pharmachem (India) LimitedRajasthan | Test for Dissolution of TabletsDissolution | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets IP 650mg (Parvis-650) | SPT-36695Mfg 2023-10 · Exp 2025-09 | Shervotee PharmaceuticalsHimachal Pradesh | DissolutionDissolution | SFTRL, Odisha BhubaneswarState lab |
| Paracetamol Tablets IP 500 mg, | BTH-19Mfg 2025-02 · Exp 2027-01 | Bengal Chemicals And Pharmaceuticals E-35 Industrial Area Haridwar-249401 UKUttarakhand | The Sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Test For Dissolution Only.Dissolution | CDTL, HyderabadCDSCO lab |
| Paracetamol Tablets IP (Leemol-500) | AOPT24013SMfg 2023-12 · Exp 2026-11 | Leeford Healthcare LtdHimachal Pradesh | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Paracetamol Tablets I.P. (500 mg) | PCT1210Mfg 2024-08 · Exp 2026-07 | Unicure India Ltd. C-21Uttar Pradesh | The sample does not conform to I.P with respect to the test for Dissolution.Dissolution | CDTL, IndoreCDSCO lab |
| Paracetamol Tablets I.P 650 mg (Alpa-650 Tablets) | 2501032Mfg 2025-01 · Exp 2027-12 | Aban PharmaceuticalsKerala | Test for Dissolution of TabletsDissolution | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol Tablets I.P -500 mg | DGT 24-25Mfg 2024-11 · Exp 2026-10 | Ornate Labs Pvt. LtdBihar | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Paracetamol Tablets I.P -500 mg | DGT 24-232Mfg 2024-11 · Exp 2026-10 | Ornate Labs Pvt. LtdBihar | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Paracetamol Paediatric Oral Suspension IP (LOWFE-250) | CL-24098Mfg 2025-02 · Exp 2027-01 | Casid Pharmaceuticals Pvt.LtdTamil Nadu | Failed in AssayAssay | DTL, PuducherryState lab |
| Paracetamol Infusion I.P (1.0% w/v)-Neomol I.V. | T383L935Mfg 2025-03 · Exp 2027-02 | Truelixir Life Sciences Private. LimitedMaharashtra | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Paracetamol I.P 650 mg (SINDOL 650 TABLETS) | ALT0841Mfg 2024-04 · Exp 2026-03 | Arcon LabsHimachal Pradesh | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL PATNAState lab |
| Paracetamol I.P 650 mg (PC-WIN 650 ) | VGT 241580BMfg 2024-08 · Exp 2026-07 | Vrindavan GlobalHimachal Pradesh | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Paracetamol I.P 500 mg (PARA 500) | NBRT-018Mfg 2023-05 · Exp 2026-04 | Laborate Pharmaceuticals India LtdHimachal Pradesh | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Paracetamol I.P 500 mg (PARA 500) | NBRT-018Mfg 2023-05 · Exp 2026-04 | Laborate Pharmaceuticals India LtdHimachal Pradesh | The Sample does not conform to I.P specification with respect to "Dissolution" for ParacetamolDissolution | BDCL, PATNAState lab |
| Pantoprazole Gastro-resistant and Domperidone Tablets IP | DL-57Mfg 2024-10 · Exp 2026-09 | Dutch Formulations 32Himachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Disintegration (Acid stage), Assay of Domperidone, Pantoprazole Sodium Calculated As Pantoprazole.Assay | RDTL, ChandigarhCDSCO lab |
| Pantoprazole Gastro-Resistant Tablets IP (Astepan-40) | BCT25-0153Mfg 2025-04 · Exp 2027-03 | Biocenna Healthcare Pvt.Ltd.Kh.No.218Uttarakhand | Dissolution for PantoprazoleDissolution | SDTL,Andhra Pradesh, VijayawadaState lab |
| Oxcarbazepine Tablets IP 150 mg (OXCARBAJAJ 150) | OXA01A25Mfg 2025-01 · Exp 2026-12 | Bajaj Healthcare Ltd. R.S. No. 1818Gujarat | The Sample Received Does Not Conform To I.P. 2022 Specification With Respect To The Description Only.Description | CDTL, HyderabadCDSCO lab |
| Ovocet-M (Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP) | LV24MT-048CMfg 2024-12 · Exp 2026-11 | L.V. Life SciencesHimachal Pradesh | Test for Dissolution of Montelukast onlyDissolution | DTL, Bengaluru, KarnatakaState lab |
| Ofloxacin and Ornidazole Tablets IP (Oflogard-O) | TLT1005BMfg 2024-12 · Exp 2026-11 | Amster Labs LimitedHimachal Pradesh | DescriptionDescription | DTL, Bengaluru, KarnatakaState lab |
| Ofloxacin and Ornidazole Tablets (02 Tablets ) | E41580Mfg 2024-10 · Exp 2028-09 | Medley Pharmaceuticals Ltd. Lane no 3Jammu & Kashmir | The Sample does not conform to I.P specification with respect to identification and content of Ofloxacin and OrnidazoleIdentification | BDCL, PATNAState lab |
| Ofloxacin and Ornidazole Tablets (02 Tablets ) | E40114Mfg 2024-01 · Exp 2026-12 | Medley Pharmaceuticals Ltd. Lane no 3Jammu & Kashmir | The Sample does not conform to I.P specification with respect to identification and content of Ofloxacin and OrnidazoleIdentification | BDCL, PATNAState lab |
| Nuromine PG 37.5 | MLS-241642Mfg 2025-03 · Exp 2027-02 | Maskon Life Sciences Pvt. Ltd. Kh. No. 69-70 KhatakheriUttarakhand | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Nitrazepam I.P. 10mg tablets(NITRVET 10) | AXZ24003PMfg 2024-01 · Exp 2028-06 | Anglo-French Drugs & Industries LtdKarnataka | The Sample does not conform to I.P specification with respect to identification and content of NitrzepamIdentification | BDCL, PATNAState lab |
| Nitrazepam I.P. 10mg tablets(NITRVET 10) | AXZ24003PMfg 2024-01 · Exp 2028-06 | Anglo-French Drugs & Industries LtdKarnataka | The Sample does not conform to I.P specification with respect to identification and content of NitrzepamIdentification | BDCL, PATNAState lab |
| Nitrazepam I.P. 10mg tablets(NITRVET 10) | 10233PMfg 2022-10 · Exp 2027-03 | Anglo-French Drugs & Industries LtdKarnataka | The Sample does not conform to I.P specification with respect to identification and content of NitrzepamIdentification | BDCL, PATNAState lab |
| Nimuris Cold & Flu Tablets | GT027502Mfg 2025-02 · Exp 2027-01 | Asian Pharma Kh. No -105-106 Village KathaHimachal Pradesh | NSQOther | DTL Baddi H.PState lab |
| Nicofast-5 (Nicorandil Tablets IP) | ONTT2404Mfg 2025-03 · Exp 2027-02 | Goodman PharmaceuticalsPuducherry | Dissolution & ContentDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Neckline Lip Fashion Lipstick [Neckline Ultima III Lip color (on carton)] | NL05Mfg 2025-05 · Exp 2028-04 | Kanero CosmeticsDelhi | Test For Break Load Value.Other | NCT of DelhiState lab |
| Mymi D (Alpha Lipoic Acid, Pyridoxine Hydrochloride, Methylcobalamin, Folic Acid & Vitamin D3 Tablets) | HT24673Mfg 2024-12 · Exp 2026-11 | HBC Healthcare Pvt. LtdGujarat | Test for Disintegration onlyDisintegration | DTL, Bengaluru, KarnatakaState lab |
| Montelukast and Levocetirizine Tablets IP (Montilax Tablets) | ATD052BMfg 2024-04 · Exp 2026-03 | Haustus Biotech Pvt Ltd | AssayAssay | DTL Baddi H.PState lab |
| Montelukast Sodium & Levocetirizine Dihydrochloride Tablets IP (ZAL-M Tablets) | JMT-2504057Mfg 2025-04 · Exp 2027-03 | JMM Laboratories Village: KhariHimachal Pradesh | The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay and Dissolution" for Montelukast.Assay | RDTL, GuwahatiCDSCO lab |
| Montecas-L Syrup (Levocetirizine & Montelukast) | BCRL2407068Mfg 2024-07 · Exp 2026-06 | Casca Remedies Pvt. LtdHaryana | Assay of Montelukast onlyAssay | DTL, Bengaluru, KarnatakaState lab |
| Misoprostol Tablets IP 100mcg | TM-1480005Mfg 2025-02 · Exp 2027-01 | Centurion Remedies Pvt. LtdGujarat | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Meurozen-D3 Softgel Capsules (Methylcobalamin, Alpha Lipoic Acid, Folic Acid, Pyridoxine HCL & Vitamin D3 Softgel Capsules) | HPDC25248Mfg 2025-03 · Exp 2027-02 | Healthwise PharmaHimachal Pradesh | Test for Disintegration and with respect to label claim of Assay for Pyridoxine HCL and Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Metoprolol Succinate (ER) & Amlodipine Besylate Tablets IP (Metorell-AM 50 Tablets) | 77BG08Mfg 2025-06 · Exp 2027-05 | Sarv PharmaceuticalsUttarakhand | Uniformity of Weight? and ?Test for Dissolution for AmlodipineDissolution | DTL, Bengaluru, KarnatakaState lab |
| Methylcobalamin Tablets USP 500 mcg | G250050/2Mfg 2025-04 · Exp 2027-03 | Vee Excel Drugs & Pharmaceuticals (P) Ltd. B-1/AUttar Pradesh | The sample does not conform to claim as per USP 2024 in respect to the Assay of MethylcobalaminAssay | RDTL, ChandigarhCDSCO lab |
| Metformin Hydrochloride (SR) & Glimepride Tablets IP (Yathoglim-M3) | T25C554AMfg 2025-03 · Exp 2027-02 | Bajaj FormulationsUttarakhand | Sample fail the test Assay of Glimepiride.Assay | RDTL, Ernakulam, KeralaState lab |
| Meloxicam Paracetamol & Serratiopeptidase Bolus (vet) | T-25095Mfg 2025-05 · Exp 2027-04 | Minil Laboratories Pvt. Ltd. 26Jammu & Kashmir | The sample does not conform to the claim with respect to Description as it show physical instabillity in the form of Mottling.Description | DTL, JaipurState lab |
| Lycopene, Anti-oxidant, Multivitamin and Multimineral Syrup (Lycoanvit Plus Syrup) | OL-24419Mfg 2024-09 · Exp 2026-02 | Orchid Bio-Tech Ltd. 65Delhi | The sample does not conform to claim as per Patent and Proprietary in respect to the Test of Identification and Assay of Folic acid, Cyanocobalamin, Copper Sulphate, Vitamin D3, Calcium PantothenateAssay | RDTL, ChandigarhCDSCO lab |
| Luliconazole Cream IP 1% w/w | H017Mfg 2024-04 · Exp 2026-03 | Merril Pharma Pvt. Ltd. Plot No. 212Uttarakhand | The sample does not conform to I.P 2022 with respect to the content of Luliconazole.Other | CDTL, IndoreCDSCO lab |
| Losartan Potassium & Amlodipine Tablets IP | TL-1470007Mfg 2023-12 · Exp 2026-11 | Centurion Remedies Pvt. LtdGujarat | The sample does not conform to the IP with respect to Assay and Dissolution.Assay | DTL, JaipurState lab |
| Loperamide Hydrochloride Tablets IP 2 MG (Lomorex Tablets) | CT-7350Mfg 2024-04 · Exp 2027-03 | Chemetac Pharmaceuticals 42 Maina PurUttar Pradesh | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Loperamide Hydrochloride.Dissolution | RDTL, GuwahatiCDSCO lab |
| Loperamide HCI Tablet IP (KARLOP) | T-17075Mfg 2025-04 · Exp 2027-03 | Karnani Pharmaceuticals(P) Ltd. 38Uttarakhand | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Liposomal Amphotericin B Injection 50 mg (Gufisome 50 mg/vial) | AA241096BMfg 2024-12 · Exp 2026-11 | Gufic Biosciences Ltd. N.H.No. 08 KabilporeGujarat | The sample does not conform to Manufacturer specification with respect to Clarity of solution, pH, reconstitution time, Particulate Matter, Free Drug and Assay of amphotericin B.Assay | CDL, KolkataCDSCO lab |
| Liposomal Amphotericin B Injection 50 Mg (Gufisome) | AB240590BMfg 2024-12 · Exp 2026-11 | Gufic Biosciences Ltd. National Highway No. 8Gujarat | The sample does not conform to Manufacturer's Specification with respect to test for pH, Free Drugs, Particulate Matter, Reconstitution Time, Clarity Of Solution and AssayAssay | CDL, KolkataCDSCO lab |
| Lindane Lotion USP 1% | LNE-1020Mfg 2025-08 · Exp 2027-07 | Wings Biotech LLPHimachal Pradesh | The above product is official in IP 2022 (Addendum 2024 W.e.f july 2024) but it is claimed as USP as on Manufacturing date.Other | SDTL, PunjabState lab |
| Levocetirizine Dihydrochloride Tab (Wineet-L) | YLT25023Mfg 2025-03 · Exp 2027-02 | YL Pharma Plot No. 9(H)1 Village-Katha Baddi Dist Solan (H.P)Himachal Pradesh | The sample does not conform to the IP as it does not contain Levocetirizine DihydrochlorideOther | DTL, JaipurState lab |
| Levocetirizine Dihydrochloride & Montelukast Sodium Orally Disintegrating Tablets (MONSTAR-LC KID) | TL-23109Mfg 2023-12 · Exp 2025-11 | Horizon Bioceuticals Pvt. LtdHimachal Pradesh | Average weight and Assay (for Levocetirizine Dihydrochloride )Assay | DTL, PuducherryState lab |
| Labetalol Injection IP | L0422420FMfg 2024-12 · Exp 2026-11 | Protech TelelinksHimachal Pradesh | pHpH | King Institute of Preventive Medicine & Research, Guindy, Chennai-32State lab |
| L-Lysine Hydrochloride Ointment (Lycimond) | 25006Mfg 2025-07 · Exp 2027-06 | Diamond Drugs Pvt. Ltd 94West Bengal | The sample does not conform to claim with respect to test for Microbial Limits.Microbial limits | CDL, KolkataCDSCO lab |
| Kufnas-Am Syrup (Ambroxol, Terbutaline, Sulphate, Guaiphenesin & Menthol Syrup) | SL241158TMfg 2024-12 · Exp 2026-11 | Star Filteration SystemsHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Khasigo-LS Syrup (Levosalbutamol Sulphate, Ambroxol Hydrochloride Guaiphenesin Syrup) | SP244505Mfg 2024-12 · Exp 2026-11 | Sotac Pharmaceuticals LtdGujarat | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| KAAMRAJ Caspules (Suspected to contain Sildenafil and Tadalafil | BAC0005Mfg 2024-11 · Exp 2027-10 | Brahmanand Ayurveda (OPC) Pvt. LtdPunjab | IdentificationIdentification | SDTL, PunjabState lab |
| Itraconazole Capsules BP 200 mg (Itradot-200 Capsules) | ALC-1509Mfg 2024-12 · Exp 2026-11 | Access Life ScienceHimachal Pradesh | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Intraconazole Capsules 100 mg (ITRASEC-100) | C24I028DMfg 2024-09 · Exp 2026-08 | Bajaj Formulations Khasra No. 161Uttarakhand | The sample does not conform to I.P. Addendum 2024 with respect to the Dissolution of Itraconazole.Dissolution | CDL, KolkataCDSCO lab |
| Ibuprofen and Paracetamol Tablets IP | NCJ-02Mfg 2025-04 · Exp 2027-03 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Hyoscine Butylbromide & Paracetamol Tablets (Hyofem) | GENT10520Mfg 2025-03 · Exp 2027-02 | Gentech Healthcare Pvt Ltd | Assay and DescriptionAssay | DTL, JaipurState lab |
| Glucosamine Sulphate Potassium Chloride, Msm With Diacerein Tablets (LYCEREIN PLUS) | LYP-2503Mfg 2025-08 · Exp 2027-07 | Life Line PharmaPuducherry | Incorrect labellingLabelling | DTL, PuducherryState lab |
| Glimpiride Tablets I.P. 2 MG. | SGYT-134Mfg 2025-03 · Exp 2027-02 | Marc Lifesciences SikkimSikkim | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| Glimpiride Tablets I.P. 2 MG. | SGYT-120Mfg 2025-02 · Exp 2027-01 | Marc Lifesciences SikkimSikkim | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| Glimpiride Tablets I.P. 2 MG. | SGYT-122Mfg 2025-02 · Exp 2027-01 | Marc Lifesciences SikkimSikkim | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| Glimpiride Tablets I.P. 1 MG. | SLY-108Mfg 2024-09 · Exp 2026-08 | Marc Lifesciences SikkimSikkim | The sample does not conform to I.P. Standard with respect to descriptive Part of the Tablet.Other | State Drugs Testing Laboratory, Kolkata, West BengalState lab |
| Glimilive-M2 (Glimepiride and Metformin Hydrochloride Prolonged Release Tablets IP) | G522501BMfg 2025-02 · Exp 2027-01 | Lifecare Formulations Pvt. LtdPuducherry | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Glimepiride, Pioglitazone & Metformin (Extended Release) Tablets (AXYLIM-PM 1 Tablets) | 424-73Mfg 2024-01 · Exp 2026-06 | Zee Laboratories 47Himachal Pradesh | The sample does not conform to claim as per Manufacturer Specification with respect to the test for "Assay" of Pioglitazone Hydrochloride equivalent to Pioglitazone.Assay | RDTL, GuwahatiCDSCO lab |
| Glimepiride Tablets IP (Glimilex 1) | V24457Mfg 2024-11 · Exp 2026-10 | APY PharmaAssam | Sample fail the test Dissolution as per IPDissolution | DTL, Thiruvananthapuram, KeralaState lab |
| Frusemide Tablets IP 40 mg | T021906-25Mfg 2025-06 · Exp 2027-05 | Adsila Organics Pvt. Ltd. Liwaspur RoadHaryana | The sample does not conform to claim as per IP 2022 in respect to the Test of Dissolution.Dissolution | RDTL, ChandigarhCDSCO lab |
| Flupentioxol & Melitracen Tablets (Flupen-Clam) | TSF-D0651Mfg 2025-03 · Exp 2027-02 | Spen Formulations Pvt. Ltd. Plot No. 123 | The sample does not conform to the claim with respect to Assay of Flupentixol.Assay | DTL, JaipurState lab |
| Ferric-XT Syrup (Ferrous Ascorbate IP Folic Acid IP Syrup) | DL 3214Mfg 2024-10 · Exp 2026-09 | Dexter Formulation Pvt.Ltd | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Fenofibrate Tablets I.P. 160 mg | MT250955Mfg 2025-03 · Exp 2027-02 | Mascot Health Series Pvt.Ltd. Plot No. 79Uttarakhand | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Fenofibrate.Dissolution | RDTL, GuwahatiCDSCO lab |
| FOLIC ACID TABLETS IP 5mg (FOLIC ACID TABLETS IP 5mg) | TFN25012ALMfg 2025-07 · Exp 2027-06 | HINDUSTAN LABORATORIES LIMITEDMaharashtra | Uniformity of contentUniformity of weight/content | SDTL, PunjabState lab |
| Everan (Paracetamol Injection 75mg/ml) | EL2PC-07Mfg 2024-12 · Exp 2026-11 | Bio Medica Laboratories LtdMadhya Pradesh | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Esyfol-XT (Calcium Carbonate, Vitamin D3, Methylcobalamin, L-Methylfolate Calcium & Pyridoxal-5 Phosphate Tablets) | GFTP25214Mfg 2025-05 · Exp 2027-04 | Genip Formulations Pvt. LtdHimachal Pradesh | Test for Uniformity of weight? and does not conform to label claim with respect to ?Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Drotaverine Hydrochloride & Mefenamic Acid Tablets (SPASMIC) | UT6035Mfg 2024-05 · Exp 2027-04 | Uttaranchal Pharmaceuticals Pvt Ltd. Kh No. 673Uttarakhand | The Sample does not conform to the claim with respect to colour presence of Quinoline Yellow in place of Erythrosine on label claimLabelling | DTL, JaipurState lab |
| Doxycycline Capsules IP 100mg | DXC24014Mfg 2024-06 · Exp 2027-05 | Vivek Pharmachem (India) LtdRajasthan | Test for Uniformity of Weight of CapsulesUniformity of weight/content | DTL, JaipurState lab |
| Docetaxel Injection IP (Adoxi)Combipack of (a) 1 vial of Docetaxel Injection IP (50mg in 2ml) | (a) 8DTI2401V (b) 8SLI2401YMfg ? · Exp ? | Beta Drugs Ltd. Kharuni Lodhimajjra RoadHimachal Pradesh | fail the test AssayAssay | DTL, Thiruvananthapuram, KeralaState lab |
| Docetaxel Injection IP (ADOXI) [Combipack of (a) 1 vial of Docetaxel Injection IP (20mg in 0.5ml) | (a)BDTI2401ZA (b) BSLI2402ZMfg ? · Exp ? | Beta Drugs Ltd. Kharuni Lodhimajjra RoadHimachal Pradesh | fail the test AssayAssay | DTL, Thiruvananthapuram, KeralaState lab |
| Dicyclomine hydrochloride & Mefenamic Acid Tablets IP | WT-1025Mfg 2025-08 · Exp 2027-07 | Wilcure Remedies Pvt LtdMadhya Pradesh | The cited product is official in I.P which is not printed on the strips of above refered sample.Other | SDTL, PunjabState lab |
| Dicyclomine hydrochloride & Mefenamic Acid Tablets | WT-1026Mfg 2025-08 · Exp 2027-07 | Wilcure Remedies Pvt LtdMadhya Pradesh | The cited product is official in I.P which is not Printed on the strips of above refered sample.Other | SDTL, PunjabState lab |
| Dicvis Gel (Diclofenac Diethylamine, Methyl Salicylate, Linseed Oil & Menthol Gel) | FDE581Mfg 2024-02 · Exp 2026-01 | Fine Drugs & Skin CareHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Diclofenac Sodium Tablets IP 50mg(Reactin 50) | G25RDA016Mfg 2025-03 · Exp 2027-02 | Acme Generics Pvt. Ltd. Plot no. 115 HPSIDCHimachal Pradesh | Sample fail the test DissolutionDissolution | DTL, Thiruvananthapuram, KeralaState lab |
| Diclofenac Sodium Tablets I.P. 50 mg | DT24-62Mfg 2024-10 · Exp 2026-09 | Leostar Healthcare Pvt. Ltd. Sy No. 321Telangana | Disintegration and DescriptionDescription | DCL TelanganaState lab |
| Diclofenac Potassium and Paracetamol Tablot (LIFOGESIC) | 142Mfg 2023-11 · Exp 2026-10 | Rajdip PharmaceuticalsGujarat | Description and Test for Uniformity Weight of TabletsDescription | DTL, Bengaluru, KarnatakaState lab |
| Dextromethorphan HBr, Chlorpheniramine Maleate, Phenylephrine HCl Syrup (GESIDRYL DMR Cough Syrup) | S-715Mfg 2025-06 · Exp 2027-05 | Alpha Pharmaceuticals 41Haryana | The sample does not conform to claim with respect to "Assay of Phenylephrine Hydrochloride".Assay | CDL, KolkataCDSCO lab |
| Dexamethasone Tablets IP 0.5mg | TA24665Mfg 2024-08 · Exp 2026-07 | Saintlife Pharmaceuticals LtdUttarakhand | Dissolution & ContentDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Dexamethasone Tablets IP (Doxomax) | T-16976Mfg 2025-03 · Exp 2027-02 | 38Uttarakhand | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| Dexamethasone Sodium Phosphate Injection IP (Dexona) | N400726Mfg 2023-06 · Exp 2025-11 | Zydus Healthcare Ltd. At: PF 61 & 62Gujarat | Assay and Particulate matter, of Description.Assay | CDL, KolkataCDSCO lab |
| Deflazacort Tablets (Shedef) | MDT-3876Mfg 2025-03 · Exp 2027-02 | Mayasha LifesciencesHimachal Pradesh | Assay of Deflazacort. 3.45mg (57.5%) found as claimed 6 mg)Assay | DTL Baddi H.PState lab |
| Dazfol-D Softgel Capsules (Methylcobalamin, Pyridoxine Hydrochloride, Docosahexaenoic Acid (DHA) & Folic Acid Softgel Capsules) | ALD5090EMfg 2025-02 · Exp 2027-01 | Amster Labs LimitedHimachal Pradesh | Assay for Pyridoxine HydrochlorideAssay | DTL, Bengaluru, KarnatakaState lab |
| DICLOFIT Plus (Diclofenac Sodium & Paracetamol Tablets IP) | M-9475Mfg 2025-01 · Exp 2026-12 | Herb Edge Health Care Pvt. Ltd | Test for Uniformity of weight? onlyUniformity of weight/content | DTL, Bengaluru, KarnatakaState lab |
| DENOCK N | SLTC24010Mfg 2024-03 · Exp 2026-02 | SWIFT LIFE SCIENCES PVT. LTDUttarakhand | The content of Naloxone found to be 0.1169 mg per tablet (116.9%) labelled claim of 0.1mg per tabletLabelling | SDTL, PunjabState lab |
| Compound Sodium Lactate InjectionI.P. (Ringer Lactate Solution for Injection) (RL 500ml) | CG240705033Mfg 2024-07 · Exp 2027-06 | Vision Parental Pvt. Ltd | The sample does not conform to I.P. with respect to test for Sterility.Sterility | CDL, KolkataCDSCO lab |
| Compound Benzoin Tincture I.P | TB132Mfg 2025-01 · Exp 2026-12 | Apex Healthcare | Tests for weight per ml. Total solids and Assay for Total balsamic Acids (as Cinnamic Acid)?Assay | DTL, Bengaluru, KarnatakaState lab |
| Coldrif Syrup (Paracetamol, Phenylephrine Hydrochloride, Chlorpheniramine Syrup) | SR-13Mfg 2025-05 · Exp 2027-04 | Sresan Pharmaceutical ManufacturerKarnataka | AdulteratedAdulterated | Drugs Testing Laboratory, Chennai-06State lab |
| Co-Trimoxazole Tablets IP (Sevzole) | CHT23515Mfg 2024-01 · Exp 2025-12 | Cureza Healthcare Pvt. Ltd. A.B. Road | DescriptionDescription | FDAL, MumbaiState lab |
| Clopidogrel and Aspirin Tablets IP (75 mg/75 mg) | Z24-293Mfg 2024-04 · Exp 2026-03 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conform to I.P with respect to DissolutionDissolution | CDL, KolkataCDSCO lab |
| Clopidogrel Tablets IP (Lavix-75) | 52-018Mfg 2024-09 · Exp 2027-08 | Signature Phytochemical Industries 122Uttarakhand | The sample does not conform to I.P 2022 with respect to the test test for DissolutionDissolution | CDTL, IndoreCDSCO lab |
| Cloberasol Propionate and Salicylic Acid Ointment | 1210CSOMfg 2025-03 · Exp 2027-02 | Unicure India LtdUttar Pradesh | ContentOther | Drugs Testing Laboratory, Chennai-06State lab |
| Clobazam Tablets IP 5 mg | 01283Mfg 2024-09 · Exp 2026-08 | Healthy Life Pharma Pvt. Ltd. Factory: N-31/1Maharashtra | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Ciprofloxacin Tablets IP 500 mg | TB250356Mfg 2025-05 · Exp 2027-04 | Agron Remedies Pvt. Ltd. SarverkheraUttarakhand | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Cinchocaine Hydrochloride EP | DH/001/01/24Mfg 2024-01 · Exp 2028-12 | Pioneer Agro Industries Sanvin Laboratories Pvt Ltd. Plot No. 6Maharashtra | The sample received does not conform to EP-11 with respect to the test for Related substances..Related substances | CDTL, MumbaiCDSCO lab |
| Chlorpheniramine Tablets IP 4mg | T-6763Mfg 2025-08 · Exp 2027-07 | Jackson Laboratories Pvt Ltd | Failed in DissolutionDissolution | DTL, PuducherryState lab |
| Cefpodoxime Proxetil Tablets IP 200mg | MBT 24019Mfg 2024-06 · Exp 2026-05 | Mancare Laboratories Pvt.LtdUttarakhand | It fails the test Dissolution as per IPDissolution | DTL, Thiruvananthapuram, KeralaState lab |
| Cefpodoxime Proxetil Tablets I.P. 200 mg (Cefporeg-200) | APT24-017Mfg 2024-04 · Exp 2026-03 | Regal Laboratories | Test for DissolutionDissolution | DTL, Bengaluru, KarnatakaState lab |
| Cefpodoxime Proxetil & Potassium Clavulanate Tablets IP (Efodoxime-CV Tablets) | MYRTAB-655Mfg 2024-09 · Exp 2026-02 | Mayer LabHimachal Pradesh | Assay for Clavulanic AcidAssay | DTL, Bengaluru, KarnatakaState lab |
| Cefixime, Azithromycin & Lactic Acid Bacillus Tablets (CEFICO- AZ TABLETS) | AP-241242Mfg 2025-01 · Exp 2026-12 | Park Pharmaceuticals 272 Ind. Area Phase IIHaryana | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Carbamazepine Tablets IP | GFTP25317Mfg 2025-05 · Exp 2027-04 | Genip Formulations Pvt. LtdHimachal Pradesh | Assay for CarbamazepineAssay | SDTL,Andhra Pradesh, VijayawadaState lab |
| Calcium and Vitamin D3 Tablets. I.P | CBT-0037Mfg 2025-05 · Exp 2026-10 | Crossia Biotech Pvt.Ltd | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of CalciumDissolution | Drugs Testing Laboratory,MeghalayaState lab |
| Calcium and Vitamin D3 Tablets IP(Calse-D3) | CHPLT562Mfg 2024-12 · Exp 2026-05 | Cureza Healthcare Pvt. Ltd. Survey No. 63/1Madhya Pradesh | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium and Vitamin D3 Tablets IP (Tricium-XT) | 1250077Mfg 2025-01 · Exp 2026-06 | Corona Remedies LtdHimachal Pradesh | Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Calcium and Vitamin D3 Tablets IP (Calse-D3) | CHPLT538Mfg 2024-12 · Exp 2026-05 | Cureza Healthcare Pvt. Ltd. Survey No. 63/1Madhya Pradesh | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium and Vitamin D3 Tablets I.P. 500mg/250 I.U | OJCT-009Mfg 2024-12 · Exp 2026-11 | Laborate Pharmaceuticals India Ltd. # 31Himachal Pradesh | Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Calcium and Vitamin D3 Tablets I.P. (Crosscal-D) | CBT-0037Mfg 2025-05 · Exp 2026-10 | Crossasia Biotech Pvt. Ltd. Survey No. 488 | The sample does not comply as per I.P. 2022 with respect to the test for "Dissolution" of Calcium.Dissolution | RDTL, GuwahatiCDSCO lab |
| Calcium Gluconate Injection USP 10% w/v | KBU24001Mfg 2025-09 · Exp 2027-08 | Farbe firma Pvt Ltd. Plot No.: 1508Gujarat | The sample received does not conform to the I.P. 2022 standard with respect to the test for Bacterial endotoxins, Particulate contamination and Sterility.Sterility | CDTL, MumbaiCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (CALXIA 500 TABLETS) | GTA1352Mfg 2025-01 · Exp 2026-12 | Gidsha Pharmaceuticals Plot No. 611 612Gujarat | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU TABLETS IP (CALXIA 500 TABLETS) | GTA1351Mfg 2025-01 · Exp 2026-12 | Gidsha Pharmaceuticals Plot No. 611 612Gujarat | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | GT-240203Mfg 2024-11 · Exp 2026-10 | Helax Health Care Pvt. Ltd. Khasra No.410Uttarakhand | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | GT-240202Mfg 2024-11 · Exp 2026-10 | Helax Health Care Pvt. Ltd..Khasra No.410Uttarakhand | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | GT-240219Mfg 2024-11 · Exp 2026-10 | Helax Health Care Pvt. Ltd. Khasra No.410Uttarakhand | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets IP (SENCAL - 500) | GT-240204Mfg 2024-11 · Exp 2026-10 | Helax Health Care Pvt. Ltd. Khasra No.410Uttarakhand | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets I.P (DPCAL-500) | GT17894CMfg 2025-02 · Exp 2027-01 | J.M. LaboratoriesHimachal Pradesh | Test for Dissolution for Calcium and Assay for Vitamin D3Assay | DTL, Bengaluru, KarnatakaState lab |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | M24097Mfg 2024-09 · Exp 2026-02 | Mercury Pharmaceuticals Vill-BersonHimachal Pradesh | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | M24120Mfg 2024-11 · Exp 2026-04 | Mercury Pharmaceuticals Vill-BersonHimachal Pradesh | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (TISE-CAL) | M24099Mfg 2024-09 · Exp 2026-02 | Mercury Pharmaceuticals Vill-BersonHimachal Pradesh | The sample does not conform to claim as per IP 2022 With respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | VDFT-270Mfg 2024-12 · Exp 2026-11 | Vzoic Healthcare Pvt. Ltd.Plot No. 236Punjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | VDFT-269Mfg 2024-12 · Exp 2026-11 | Vzoic Healthcare Pvt. Ltd. Plot No. 236Punjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | VDFT-271Mfg 2024-12 · Exp 2026-11 | Vzoic Healthcare Pvt. Ltd.. Plot No. 236Punjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | VDFT-274Mfg 2024-12 · Exp 2026-11 | Vzoic Healthcare Pvt. Ltd.. Plot No. 236Punjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | VDFT-273Mfg 2024-12 · Exp 2026-11 | Vzoic Healthcare Pvt. Ltd.Plot No. 236Punjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate & Vitamin D3 Tablets (Aemcal-D3) | VDFT-272Mfg 2024-12 · Exp 2026-11 | Vzoic Healthcare Pvt. Ltd.Plot No. 236Punjab | Dissolution and AssayAssay | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (Calxia500) | GTA1340Mfg 2025-01 · Exp 2026-12 | Gidsha Pharmaceuticals Plot No. 611 612Gujarat | The sample does not conform to IP with respect to test for DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (CALXIA 500) | GTA1354Mfg 2025-01 · Exp 2026-12 | Gidsha Pharmaceuticals Plot No. 611 612Gujarat | The sample does not conform to IP with respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (CALXIA 500) | GTA1348Mfg 2025-01 · Exp 2026-12 | Gidsha Pharmaceuticals Plot No. 611 612Gujarat | The sample does not conform to claim as per IP 2022 in respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium Carbonate 500 MG + VIT. D3 250 IU Tablets IP (CALXIA 500) | GTA1346Mfg 2025-01 · Exp 2026-12 | Gidsha Pharmaceuticals Plot No. 611 612Gujarat | The sample does not conform to IP with respect to the Test of DissolutionDissolution | CDL, KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets IP (500 mg/250IU) | CDA-586Mfg 2025-03 · Exp 2027-02 | Healers LabHimachal Pradesh | The sample does not comply as per I.P. 2022 with respect to the Test for "Assay" of Vitamin D3 and "Dissolution" for Calcium.Assay | RDTL, GuwahatiCDSCO lab |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | M24122Mfg 2024-11 · Exp 2026-04 | Mercury Pharmaceuticals Vill-BersonHimachal Pradesh | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | M24119Mfg 2024-11 · Exp 2026-04 | Mercury Pharmaceuticals Vill-BersonHimachal Pradesh | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | M24098Mfg 2024-09 · Exp 2026-02 | Mercury Pharmaceuticals Vill-BersonHimachal Pradesh | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab |
| Calcium & Vitamin D3 Tablets (TISE-CAL) | M24121Mfg 2024-11 · Exp 2026-04 | Mercury Pharmaceuticals Vill-BersonHimachal Pradesh | The sample does not conform to claim as per IP 2022 with respect to AssayAssay | CDL, KolkataCDSCO lab |
| Buprenorphine and Naloxone Sublingual Tablets IP (Adnomore-N) | ADN5001Mfg 2025-04 · Exp 2028-02 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP (Adnomore-N) | ADL5001Mfg 2025-06 · Exp 2028-05 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP | QP-250411Mfg 2025-05 · Exp 2027-04 | QUBIT Pharmaceuticals Pvt. Ltd | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP | ATN5006Mfg 2025-07 · Exp 2028-06 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP | ATN4007Mfg 2024-08 · Exp 2027-07 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets IP | ATL4001Mfg 2024-03 · Exp 2027-02 | Ethicare Pharmaceuticals (P) LtdGujarat | ContentOther | SDTL, PunjabState lab |
| Buprenorphine and Naloxone Sublingual Tablets I.P. 2mg+0.5mg ( (Akknck-N)) | SLTG25022Mfg 2025-07 · Exp 2027-06 | SWIFT LIFE SCIENCES PVT. LTDUttarakhand | ContentOther | SDTL, PunjabState lab |
| Bupivacaine Injection IP | L2022410BMfg 2024-10 · Exp 2026-09 | Protech Telelinks Mouza OgliHimachal Pradesh | The sample does not conform to claim as per IP 2022 in respect to the Test of Particulate matter, DescriptionDescription | CDL, KolkataCDSCO lab |
| Bupivacaine Hydrochloride in Dextrose Injection USP (Bupivacaine Heavy) | I-1468Mfg 2024-05 · Exp 2026-04 | Jackson Laboratories Pvt.Ltd 22-24Punjab | The sample does not conform to U.S.P. with respect to Assay of Dextrose.Assay | CDL, KolkataCDSCO lab |
| Baptar NM Tablet (Pregabalin Methylcobalamin & Nortriptyline Tablets) | UGT-25134EMfg 2025-01 · Exp 2026-12 | Ultra Drugs Pvt. LtdHimachal Pradesh | AssayAssay | DTL Baddi H.PState lab |
| BUPRENORPHINE 0.4MG & NALAXONE 0.1MG TABLETS I.P (ADDNOK-N) | 29112504Mfg 2025-05 · Exp 2028-04 | Rusan Pharma LtdUttarakhand | ContentOther | SDTL, PunjabState lab |
| BUPERA N LITE | SLTE25016Mfg 2025-05 · Exp 2027-04 | SWIFT LIFE SCIENCES PVT. LTDUttarakhand | The content of Naloxone found to be 0.112mg/tablet (112%) against labelled claim of 0.1mg/tablet.Labelling | SDTL, PunjabState lab |
| BIONAC-SPAS | BT-2947Mfg 2024-10 · Exp 2027-09 | Biosearch Organics D.I.C. Indl. Estate | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Azithromycin Tablets I.P (Morzith-500 Tablets) | T-220124Mfg 2024-01 · Exp 2026-12 | Dr. Jee Pharma Pvt LtdUttarakhand | The Sample does not conform to I.P specification with respect to identification and content of AzithromicynIdentification | BDCL, PATNAState lab |
| Azithromycin Oral Suspension IP (AZAM-200) | JL-2538Mfg 2025-09 · Exp 2027-08 | Jainsons Healthcare (GMP Certified Company) Plot No. 32Uttarakhand | The sample does not conform to I.P.2022 with respect to test for "Assay of Azithromycin"Assay | CDTL, MumbaiCDSCO lab |
| Azini-100 Suspension (Azithromycin Suspension) | DL0028Mfg 2025-07 · Exp 2027-06 | Dexter Formulation Pvt. Ltd | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Atorvastatin Tablets IP 20 mg | STTC-06Mfg 2025-03 · Exp 2027-02 | Nestor Pharmaceuticals Ltd. 11Haryana | The sample fails in the Test for Description of Tablets.Description | MDTL Kathua,Jammu and KashmirState lab |
| Atorvastatin Tablets IP 10mg | CT240238AMfg 2024-07 · Exp 2026-06 | Candour PharmaceuticalsHimachal Pradesh | DissolutionDissolution | Drugs Testing Laboratory, Chennai-06State lab |
| Atorest 10 (Atorvastatin Tablets IP) | BRD250018Mfg 2025-04 · Exp 2027-03 | BRD Medilabs (Unit-II)Himachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Atenolol Tablets IP 50 mg | NHD25365AMfg 2025-05 · Exp 2027-04 | Nest Healthcare Pvt.LtdGujarat | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Aspirin Gastro-Resistance and Atorvastatin Capsules IP (75mg+10mg) | WC022502Mfg 2025-02 · Exp 2027-01 | Weldow Remedies | Sample fail the test Dissolution and Related substanceDissolution | RDTL, Ernakulam, KeralaState lab |
| Arik Syrup (Ambroxol Hydrochloride, Phenylephrine Hydrochloride, chlorpheniramine Maleate Guaiphenesin & Menthol Syrup) | 624-732Mfg 2024-10 · Exp 2026-09 | Zee LaboratoriesHimachal Pradesh | ContentOther | Drugs Testing Laboratory, Madurai-19State lab |
| Amyclox TM-LB Capsules | BC002411Mfg 2024-11 · Exp 2026-10 | Asian Pharma Kh. No -105-106 Village KathaHimachal Pradesh | NSQOther | DTL Baddi H.PState lab |
| Amoxycillin Clavulanic Acid Tablet (A Cipex-625) | 9421Mfg 2025-04 · Exp 2027-03 | Apex FormulationsHimachal Pradesh | The Sample does not conform to I.P specification with respect to identification and content of Amoxycillin and Clavulanic AcidIdentification | BDCL, PATNAState lab |
| Amoxycillin & Potassium Clavulante Tablets IP (Worclav-625) | MICTAB-2359Mfg 2025-04 · Exp 2026-09 | Micro FormulationHimachal Pradesh | Sample fail the test Dissolution and Assay of Claculanic AcidAssay | RDTL, Ernakulam, KeralaState lab |
| Amoxycillin & Potassium Clavulanate Injection I.P. | 324-869Mfg 2024-07 · Exp 2026-06 | Zee Laboratories Ltd. Behind 47Himachal Pradesh | The sample does not conform to claim as per I.P. 2022 with respect to the test for "Assay" of Amoxycillin and Clavulanic Acid.Assay | RDTL, GuwahatiCDSCO lab |
| Amoxicillin and Potassium Clavulanate Tablet I.P. (Clavam-625) | 24441792Mfg 2024-05 · Exp 2025-10 | Alkem Health ScienceSikkim | The sample does not conform to I.P. with respect to Identification and content of Amoxicillin and Clavulanic Acid.Identification | BDCL, PATNAState lab |
| Amlodipine Tablets IP 5mg | 24110214Mfg 2024-08 · Exp 2027-07 | Mercury Laboratories Ltd. Unit No. 2Gujarat | The sample does not conform to the IP with respect to Assay .Assay | DTL, JaipurState lab |
| Amlodipine Besylate and Atenolol Tablets | NPD-6637Mfg 2024-01 · Exp 2025-12 | Nuvista Pharmaceuticals Pvt. Ltd. Plot No. 48Telangana | MISBRANDED The product label should be mentioned as Amlodipine besylate and Atenolol tablets IP. But the label is mentioned as Amlodipine besylate and Atenolol tablets only.Misbranded | DCL TelanganaState lab |
| Amlodipine Besylate Tablets IP 5mg (AMLOGEN-5) | 24230171Mfg 2024-08 · Exp 2026-07 | Alkem Laboratories LtdHimachal Pradesh | Incorrect labellingLabelling | DTL, PuducherryState lab |
| Amikacin Sulphate Injection IP (Amised 100) | V250114AMfg 2025-01 · Exp 2026-12 | Oscar Remedies Pvt. Ltd | Test for SterilitySterility | DTL, Bengaluru, KarnatakaState lab |
| Amikacin Sulphate Injection I.P. 2 ml | AS-2401Mfg 2024-08 · Exp 2026-07 | Konis Pharmaceuticals Krishna Nagar - 522502 (A.P.) | Description and Particulate matterDescription | CDL, KolkataCDSCO lab |
| Ambroxol Hydrochloride, Guaiphensin, terbutaline Sulphate & Menthol Syrup (KLEANKOF-PLUS SYRUP) | GL-25045AMfg 2025-05 · Exp 2027-04 | Go-Ish Remedies Ltd. Unit-IIHimachal Pradesh | The sample does not conform to claim as per Patent and Proprietary in respect to the Assay of Ambroxol HydrochlorideAssay | RDTL, ChandigarhCDSCO lab |
| Ambroxol Hydrochloride 15mg, Terbutaline Sulphate 1.25 mg, Guaiphenesin 50 mg, Menthol 0.5 mg (NUREX-AP ) | NRA-2403Mfg 2024-12 · Exp 2026-11 | Apple Formulations Pvt.LtdUttarakhand | Assay of Ambroxol HCl (81.53%) & Terbutaline Sulphate (74.40 %)Assay | DTL Baddi H.PState lab |
| Aluminium Hydroxide, Magnesium Hydroxide, Dimethicone & Oxethazine Suspension) | CL240052AMfg 2024-03 · Exp 2026-02 | Candour PharmaceuticalsHimachal Pradesh | Assay for Dried Aluminium HydroxideAssay | DTL, Bengaluru, KarnatakaState lab |
| Alpha Lipoic Acid 300mg & Methylcobalamin 1500mcg Capsules (KOBALA PLUS) | DAL401Mfg 2024-07 · Exp 2026-06 | Synmedic LaboratoriesRajasthan | The sample does not conform to claim in respect to the test of DescriptionDescription | DTL, JaipurState lab |
| Albendazole Tablets IP 400mg | LMT240917Mfg 2024-08 · Exp 2027-01 | Life Max Cancer LaboratoriesUttarakhand | The sample does not conform to the IP with respect to Assay and Dissolution.Assay | DTL, JaipurState lab |
| Albendazole Tablets IP 400 mg (Albekal 400) | ALB05F5AMfg 2025-06 · Exp 2027-05 | Kalpraj Techno Fab Pvt. Ltd. Plot No. 24A & 24B | The sample does not conform to I.P. with respect to test for DissolutionDissolution | CDL, KolkataCDSCO lab |
| Albendazole 2.5% W/v oral Suspension | ZAS241002Mfg 2024-10 · Exp 2026-09 | Bovine Health care D.No. 5-9-206/2Telangana | MISBRANDED pH does not comply as per IP.pH | DCL TelanganaState lab |
| Aceclofenac, Paracetamol Chlorzoxazone Tablets (Nimal-MR) | DPT-2882Mfg 2024-03 · Exp 2026-02 | Dexibo Pharma Pvt. LtdUttarakhand | Failed in DescriptionDescription | DTL, PuducherryState lab |
| Aceclofenac and Paracetamol Tablets(Aceloflam Plus) | AOPT24013SMfg 2024-04 · Exp 2026-03 | Shiva Biogenetics Pharmaceuticals Pvt.LtdHimachal Pradesh | AssayAssay | SDTL Raipur ChhattisgarhState lab |
| Aceclofenac and Paracetamol Tablets | CPT946Mfg 2024-09 · Exp 2027-02 | Coastal Medicare Pvt. Ltd. RS No. 9/2Andhra Pradesh | MISBRANDED The product label should be mentioned as Acecloenac and Paracetamol Tablets IP. But the label is mentioned as Aceclofenac and Paracetamol Tablets only.Misbranded | DCL TelanganaState lab |
| Aceclofenac & Paracetamol Tablets IP (Bioace-P Tablets) | AT-1872AMfg 2025-04 · Exp 2027-03 | Azot Life Sciences Vill. ChewaHimachal Pradesh | The Sample Received Does Not Conform To I.P. Addendum 2024 Specification With Respect To The Test For Dissolutions For Aceclofenac And Paracetamol Only.Dissolution | CDTL, HyderabadCDSCO lab |
| Acclofenac, Paracetamol & Serratiopeptidase Tablets(ASPAZ) | MDT-4102Mfg 2025-05 · Exp 2027-04 | Mayasha LifesciencesHimachal Pradesh | The sample does not conform to the IP with respect to AssayAssay | DTL, JaipurState lab |
| ANESTHETIC ANTACID GEL (Medicaine Gel) | PMCG24160Mfg 2024-11 · Exp 2026-10 | Aryatech Pharma (P) LtdUttarakhand | Assay for Dried Aluminium HydroxideAssay | DTL, Bengaluru, KarnatakaState lab |
Suspected spurious batches in this alert
| Product | Batch | Labelled manufacturer | Reported by | Firm's reply |
|---|---|---|---|---|
| Trypsin-Chymotrypsin Tablets (Chymoral Forte) | 2KU6L057 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Trypsin-Chymotrypsin Tablets (CHYMORAL FORTE) | 2KU6L030 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Azithromycin I.P 500 mg Tablets (Azithral-500) | 2408000201 | Under Investigation | BDCL, PATNA | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| Telmisartan 40 mg and Amlodipine 5 mg Tablets IP (Telma-AM) | 05241217A | Under Investigation | NCT of Delhi | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
| BUPRENORPHINE INJECTION - 2ml ((NOOPHIN) | LM 18907 | Under Investigation | CDL, Kolkata | The actual manufacturer (as per label claim) has informed that the impugned batch of the product has not been manufactured by them and that it is a spurious drug. |
Check your medicine. Enter the batch number printed on the strip, bottle or carton to see whether it appears in this or any earlier alert. Check a batch number
Official sources and primary records
- Regulator
- Regulator
Changelog
- 20 Sep 2026: table generated from the CDSCO NSQ portal export (211 rows). Revised CDSCO lists are diffed on each monthly rebuild.